Search results for: Value-Based Pricing
Filter search results
International Drug Pricing Transparency
20 July 2020, 11:00pm
…the spread of COVID-19, and the factors driving their prices are under the public eye so it becomes more important than ever to understand the fundamental economics of value-based pricing….
What are the Economic Implications of Moving Away from Paying a Single Price for a Single Drug?
9 July 2018
…for multiple indications, yet assessments of value are, in most countries, based on a single price for a single drug. Where the clinical value derived from a drug varies across…
Moving the Needle on Value – OHE Launches Research on US Value-Based Healthcare
10 June 2019
…continue escalating. There is wide agreement that the growth in healthcare costs is unsustainable. Graham asked “how can we move the needle on value?” Value-based healthcare, in which healthcare is…
Payment Models for Multi-Indication Therapies
1 November 2021
…A., Zamora, B. (2020) Indication-Based Pricing (IBP) Consultation Report. OHE Consulting Report. Available from https://www.ohe.org/publications/indication-based-pricing-ibp-consultation-report. Neri, M., Towse, A. and Garau, M., 2018. Multi-Indication Pricing (MIP): Practical Solutions and Steps…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
Multi-Indication Pricing: Practical Solutions and Steps to Move Forward. A summary of an HTAi panel session. We have just published a new OHE Briefing entitled ‘Multi-Indication Pricing: Practical Solutions and…
Value Frameworks: Value in Health Special Issue
29 March 2018
…the ISPOR Special Task Force Report on US Value Assessment Frameworks. The papers provide an introduction to value frameworks; define elements of value; discuss opportunity costs and thresholds; present a review of…
Value Based Pricing in the UK
7 September 2010
…to access medicines whilst underlying uncertainty about value is reduced’. Getting ‘value based pricing’ right, he argues, is essential to timely access to new medicines for patients in the UK…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
28 October 2015
…OHE Briefing on the topic of multi-indication pricing. The briefing contains a summary of a workshop organised and facilitated by OHE and MME Europe. Multi-indication pricing (MIP) involves setting a…
Victor R. Fuchs Award for 2020 Goes to Patricia Danzon
23 June 2020
…the case of Hep C drugs. The challenge is making the demand side an effective purchaser. The case for value-based differential pricing. In Danzon, Towse and Mulcahy (2011) ‘Setting Cost-Effectiveness…